Literature DB >> 9634002

Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.

B S Zhou1, R Ker, R Ho, J Yu, Y R Zhao, J Shih, Y Yen.   

Abstract

Ribonucleotide reductase (RR) is a rate-limiting enzyme in DNA synthesis, which is responsible for controlling deoxyribonucleoside triphosphate (dNTP) pool size. It has been shown that transfection of RR M2 cDNA in human KB cells (M2-D clone) results in overexpression for the M2 subunit and resistance to hydroxyurea (HU). In this study, dNTP pool assays were performed to measure the pool sizes in six cell lines: two controls, three transfectants, and drug-induced HU-resistant (HUR) cells. Total dNTP levels among the six cell lines rose in the following order: KB wild-type, KB vector-only transfectant, M1 cDNA transfectant, M2 cDNA transfectant, M1/M2 cDNA transfectant, and HU-induced resistant clone. The dCTP levels of the cells mimicked the total dNTP pools on a smaller scale. The significant increases in the dCTP pool sizes of the M2-D, X-D, and HUR clones were proportional to their respective increases in RR activity. Relative to all other transfectants, the M1-D clone demonstrated lower dCTP levels but increased dATP pools. The M1-D clone demonstrated a significant resistance to dNTP inhibition of RR activity compared with the control KB wild-type cells. In contrast, a profound inhibition of dCTP and a decreased sensitivity to dATP inhibition was observed in M2-D, X-D, and HUR clones. In summary, M2 cDNA transfectants and HUR clones had increased RR activity as well as expanded dNTP pools, particularly dCTP, when compared with wild-type KB cells. These data provide evidence for the intertwined relationship between RR activity and dNTP pools.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634002     DOI: 10.1016/s0006-2952(98)00042-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.

Authors:  Xiaochen Wang; Xiyong Liu; Lijun Xue; Keqiang Zhang; Mei-Ling Kuo; Shuya Hu; Bingsen Zhou; David Ann; Suzhan Zhang; Yun Yen
Journal:  Biochem Biophys Res Commun       Date:  2011-05-25       Impact factor: 3.575

2.  Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Xu Wang; Jonathan E Zuckerman; Chung Hang J Choi; Bingsen Zhou; Dongsheng Wang; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Zhuo Georgia Chen; Yun Yen; Mark E Davis; Dong M Shin
Journal:  J Control Release       Date:  2012-02-08       Impact factor: 9.776

3.  The conserved Lys-95 charged residue cluster is critical for the homodimerization and enzyme activity of human ribonucleotide reductase small subunit M2.

Authors:  Xinhuan Chen; Zhijian Xu; Lingna Zhang; Hongchuan Liu; Xia Liu; Meng Lou; Lijun Zhu; Bingding Huang; Cai-Guang Yang; Weiliang Zhu; Jimin Shao
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

4.  A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Authors:  Bingsen Zhou; Leila Su; Shuya Hu; Weidong Hu; M L Richard Yip; Jun Wu; Shikha Gaur; D Lynne Smith; Yate-Ching Yuan; Timothy W Synold; David Horne; Yun Yen
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

5.  Mechanisms by which herpes simplex virus DNA polymerase limits translesion synthesis through abasic sites.

Authors:  Yali Zhu; Liping Song; Jason Stroud; Deborah S Parris
Journal:  DNA Repair (Amst)       Date:  2007-09-27

6.  An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone.

Authors:  Xiyong Liu; Bingsen Zhou; Shu Mi; Lijun Xue; Jennifer Shih; Janice Lee; Jennifer Chau; Frank Un; Yun Yen
Journal:  Biochem Pharmacol       Date:  2007-03-20       Impact factor: 5.858

7.  Reciprocal regulation of autophagy and dNTP pools in human cancer cells.

Authors:  Wei Chen; Lisheng Zhang; Keqiang Zhang; Bingsen Zhou; Mei-Ling Kuo; Shuya Hu; Linling Chen; Michelle Tang; Yun-Ru Chen; Lixin Yang; David K Ann; Yun Yen
Journal:  Autophagy       Date:  2014-05-16       Impact factor: 16.016

8.  Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis.

Authors:  Trine B Levring; Martin Kongsbak; Anna K O Rode; Anders Woetmann; Niels Ødum; Charlotte Menné Bonefeld; Carsten Geisler
Journal:  Oncotarget       Date:  2015-09-08

9.  Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis.

Authors:  Keqiang Zhang; Shuya Hu; Jun Wu; Linling Chen; Jianming Lu; Xiaochen Wang; Xiyong Liu; Bingsen Zhou; Yun Yen
Journal:  Mol Cancer       Date:  2009-02-28       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.